Internal Medicine, Infectious Disease · Redding, CA
NPI
1467431700
Since 2006
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
2175 Rosaline Ave
Redding, CA, 96001
Phone (530) 225-6000
Groups this clinician bills Medicare through
Medicare paid, 2024
$143K
1,920 services
Medicare patients, 2024
469
Average age 73
Drug cost, 2024
$831K
1,126 prescriptions
Company payments, 2025
$139
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Matthew S Miles was code 99232 (hospital e&m - subsequent), 911 times for 296 patients. In total Matthew S Miles billed 1,920 services in 14 codes, and Medicare paid $143K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 911 | 296 | $60.05 | $55K |
| 99213 Office E&M - Established | Office | 298 | 129 | $66.20 | $20K |
| 99233 Hospital E&M - Subsequent | Facility | 279 | 142 | $89.48 | $25K |
| 99222 Hospital E&M - Initial | Facility | 174 | 173 | $96.43 | $17K |
| 99223 Hospital E&M - Initial | Facility | 121 | 121 | $129.02 | $16K |
| 99213 Office E&M - Established | Facility | 44 | 23 | $51.39 | $2,261 |
| 99214 Office E&M - Established | Office | 37 | 31 | $92.14 | $3,409 |
| 99204 Office E&M - New | Office | 23 | 23 | $122.12 | $2,809 |
By year: 2022 $136K for 1,580 services; 2023 $139K for 1,745 services; 2024 $143K for 1,920 services.
Medicare prescription drug claims, 2024
In 2024, the drug Matthew S Miles prescribed most often to Medicare patients was Biktarvy (Bictegrav/Emtricit/Tenofov Ala), with 71 prescriptions and refills. In total Matthew S Miles wrote 1,126 Medicare prescriptions that cost $831K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 71 | 71 | Under 11 | $280K |
| Cephalexin Generic | 60 | 62 | 22 | $1,353 |
| Vancomycin Hcl Generic | 56 | 56 | 16 | $7,957 |
| Tivicay Dolutegravir Sodium | 45 | 45 | Under 11 | $105K |
| Cefazolin Sodium Generic | 42 | 42 | Under 11 | $4,797 |
| Ceftriaxone Ceftriaxone Sodium | 39 | 39 | Under 11 | $5,473 |
| Gabapentin Generic | 37 | 37 | Under 11 | $285 |
| Doxycycline Hyclate Generic | 30 | 36 | 14 | $568 |
| Dovato Dolutegravir Sodium/Lamivudine | 29 | 29 | Under 11 | $83K |
| Descovy Emtricitabine/Tenofov Alafenam | 29 | 29 | Under 11 | $62K |
| Daptomycin Generic | 27 | 27 | Under 11 | $10K |
| Azithromycin Generic | 26 | 30 | Under 11 | $376 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 25 | 35 | Under 11 | $606 |
| Isentress Raltegravir Potassium | 23 | 23 | Under 11 | $44K |
| Piperacillin-Tazobactam Piperacillin Sodium/Tazobactam | 23 | 23 | Under 11 | $5,390 |
Brand drugs: 269 claims; generic drugs: 857 claims; opioid claims: 36.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Matthew S Miles $139 ($139 in general payments such as food, travel and fees) from 2 companies. The largest payer was Abbvie Inc. with $121.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.